Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer

Supriya K. Saha, Christine A. Parachoniak, Krishna S. Ghanta(Center for Cancer Research), Julien Fitamant(Massachusetts General Hospital), Kenneth N. Ross(Center for Cancer Research), Mortada S. Najem(Massachusetts General Hospital), Sushma Gurumurthy(Center for Cancer Research), Esra A. Akbay(Harvard University), Daniela Sia, Helena Cornellà, Oriana Miltiadous, Chad Walesky(University of Kansas Medical Center), Vikram Deshpande(Massachusetts General Hospital), Andrew X. Zhu(Center for Cancer Research), Aram F. Hezel(University of Rochester Medical Center), Katharine Yen(Agios Pharmaceuticals (United States)), Kimberly Straley(Agios Pharmaceuticals (United States)), Jeremy Travins(Agios Pharmaceuticals (United States)), Janeta Popovici-Müller(Agios Pharmaceuticals (United States)), Camelia Gliser(Agios Pharmaceuticals (United States)), Cristina R. Ferrone(Massachusetts General Hospital), Udayan Apte(University of Kansas Medical Center), Josep M. Llovet, Kwok‐Kin Wong(Harvard University), Sridhar Ramaswamy, Nabeel Bardeesy(Massachusetts General Hospital)
Nature
July 1, 2014
Cited by 468

Abstract


Related Papers

No related papers found

Powered by citation graph analysis